Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

THC Vaporized and THC edibles

Behavior after cannabinoid cessation differed with the compound, dose and observation time in a mouse study. An early negative assessment could miss later changes, while a strong response to a synthetic agonist should not be relabeled as a THC result.

Continuous observation added information

Researchers compared repeated THC with AM2389, an experimental higher-efficacy cannabinoid agonist. They scored overt behaviors and used telemetry to record temperature and activity before, during and after five-day regimens. These were animal outcomes, not patient-reported withdrawal symptoms.

The positive and negative findings differed

AM2389 produced clearer spontaneous withdrawal-related activity changes after cessation. Effects after THC were smaller, depended on dose and were more variable in timing. In one paw-tremor comparison, the THC group’s mean increase did not reach significance, despite significant findings with AM2389.

Temperature tolerance did not describe all behavior

Tolerance developed rapidly to the temperature-lowering effect, while movement remained suppressed after drug injections. This separates adaptation during treatment from behavior after cessation and shows why one physiological measure cannot stand for the entire response.

The correct interpretation

The study supports careful choice of observation windows and challenge compounds when investigating dependence. Five days of injected exposure in mice cannot define a human withdrawal timetable after years of cannabis use. Neither the strongest synthetic-agonist result nor a null THC comparison should be generalized to every cannabinoid or person. Clinical interpretation requires the actual product, exposure history and documented symptoms.

Related analysis: a rat study’s negative withdrawal findings.

Primary research

Paronis C; Iliopoulos-Tsoutsouvas C; Papanastasiou I; Makriyannis A; Bergman J; Nikas SP. Evidence for spontaneous cannabinoid withdrawal in mice. Behavioural pharmacology (2022). DOI: 10.1097/FBP.0000000000000665.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Was Randomized in a Survey Comparing Intense Drug Experiences?

The experience being reported was selected through survey-routing procedures. The substance exposure itself was not randomly assigned. That distinction determines what a retrospective comparison can establish. Routing participants to past experiences Chwyl and colleagues’ supplied preprint analyzed 397 adults reporting on intense psilocybin, MDMA or cannabis experiences within the previous…

Spread the love

Read Article: What Was Randomized in a Survey Comparing Intense Drug Experiences?

How Do Naturalistic Human Observations Differ From Mouse Tests of Visual Prediction?

A supplied preprint combined observational human comparisons with controlled mouse experiments. Those evidence streams can inform one another without carrying the same causal weight. Recent use was observed in people West and colleagues compared visual responses in recent psychedelic users and controls. Dose and potency could not be directly established….

Spread the love

Read Article: How Do Naturalistic Human Observations Differ From Mouse Tests of Visual Prediction?

Does a Link Between Psilocybin Use and Nature Relatedness Establish Cause?

A statistical association between past psilocybin use and feeling connected to nature does not establish that taking psilocybin caused that connection. What was compared Forstmann and colleagues reanalyzed five datasets comprising 3,817 participants. Among psychedelic-experienced participants, psilocybin experience was the most reliable substance-use predictor of self-reported nature relatedness. The analyses…

Spread the love

Read Article: Does a Link Between Psilocybin Use and Nature Relatedness Establish Cause?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us